LifeStance Health Group, Inc. (LFST) stock
LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30243% above fair value
$14.17−0.31 (-2.14%)
Close on Nov 17, 2026Market cap $5.41BP/E 109.0Yield –
LifeStance Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
LifeStance Health's operating income for the twelve months ending Jun 30, 2026 was $78.43M. For fiscal 2025 it was $24.15M. The highest annual figure on record is $24.15M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.15M | – |
| FY2024 | Dec 31, 2024 | -$31.61M | – |
| FY2023 | Dec 31, 2023 | -$189.13M | – |
| FY2022 | Dec 31, 2022 | -$210.17M | – |
| FY2021 | Dec 31, 2021 | -$286.35M | -1978.8% |
| FY2019 | Dec 31, 2019 | $15.24M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $30.65M | – |
| Q1 FY2026 | Mar 31, 2026 | $22.28M | +1289.3% |
| Q4 FY2025 | Dec 31, 2025 | $18.08M | +1607.6% |
| Q3 FY2025 | Sep 30, 2025 | $7.41M | +15666.0% |
| Q2 FY2025 | Jun 30, 2025 | -$2.95M | – |
| Q1 FY2025 | Mar 31, 2025 | $1.60M | – |
| Q4 FY2024 | Dec 31, 2024 | $1.06M | – |
| Q3 FY2024 | Sep 30, 2024 | $47.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$15.95M | – |
| Q1 FY2024 | Mar 31, 2024 | -$16.77M | – |
| Q4 FY2023 | Dec 31, 2023 | -$32.27M | – |
| Q3 FY2023 | Sep 30, 2023 | -$74.36M | – |
| Q2 FY2023 | Jun 30, 2023 | -$48.41M | – |
| Q1 FY2023 | Mar 31, 2023 | -$34.09M | – |
| Q4 FY2022 | Dec 31, 2022 | -$46.01M | – |
| Q3 FY2022 | Sep 30, 2022 | -$38.84M | – |
| Q2 FY2022 | Jun 30, 2022 | -$60.47M | – |
| Q1 FY2022 | Mar 31, 2022 | -$64.85M | – |
| Q4 FY2021 | Dec 31, 2021 | -$113.76M | -4327.4% |
| Q3 FY2021 | Sep 30, 2021 | -$124.67M | -119973.1% |
| Q2 FY2021 | Jun 30, 2021 | -$47.05M | – |
| Q1 FY2021 | Mar 31, 2021 | -$881.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $2.69M | – |
| Q2 FY2020 | Jun 30, 2020 | $104.00K | – |
See a number that looks wrong?